{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T08:08:52Z","timestamp":1771488532566,"version":"3.50.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s40291-013-0021-z","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T13:24:00Z","timestamp":1358947440000},"page":"117-122","source":"Crossref","is-referenced-by-count":41,"title":["Verigene\u00ae Gram-Positive Blood Culture Nucleic Acid Test"],"prefix":"10.1007","volume":"17","author":[{"given":"Lesley J.","family":"Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"issue":"Suppl 2","key":"21_CR1","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.ijantimicag.2010.11.010","volume":"36","author":"M Paolucci","year":"2010","unstructured":"Paolucci M, Landini MP, Sambri V. Conventional and molecular techniques for the early diagnosis of bacteraemia. Int J Antimicrob Agents. 2010;36(Suppl 2):S6\u201316.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"21_CR2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3201\/eid0702.010203","volume":"7","author":"RP Wenzel","year":"2001","unstructured":"Wenzel RP, Edmond MB. The impact of hospital-acquired bloodstream infections. Emerging Infect Dis. 2001;7(2):174\u20137.","journal-title":"Emerging Infect Dis"},{"issue":"6","key":"21_CR3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ijmm.2010.04.006","volume":"300","author":"M Bauer","year":"2010","unstructured":"Bauer M, Reinhart K. Molecular diagnostics of sepsis: where are we today? Int J Med Microbiol. 2010;300(6):411\u20133.","journal-title":"Int J Med Microbiol"},{"issue":"3","key":"21_CR4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/00134384-200309000-00003","volume":"2","author":"GJ Kost","year":"2003","unstructured":"Kost GJ, Tran NK, Louie RF, et al. Rapid diagnosis of sepsis: point-of-care testing, nucleic acid testing, and the value model. Point Care. 2003;2(3):163\u201371.","journal-title":"Point Care"},{"key":"21_CR5","doi-asserted-by":"crossref","first-page":"R186","DOI":"10.1186\/cc9294","volume":"14","author":"LE Lehmann","year":"2010","unstructured":"Lehmann LE, Herpichboehm B, Kost GJ, et al. Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials. Critical Care. 2010;14:R186.","journal-title":"Critical Care"},{"issue":"6","key":"21_CR6","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589\u201396.","journal-title":"Crit Care Med"},{"issue":"5","key":"21_CR7","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1378\/chest.09-0087","volume":"136","author":"A Kumar","year":"2009","unstructured":"Kumar A, Ellis P, Arabi Y, et al. Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock. Chest. 2009;136(5):1237\u201348.","journal-title":"Chest"},{"issue":"6","key":"21_CR8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jinf.2011.08.004","volume":"63","author":"R Huttunen","year":"2011","unstructured":"Huttunen R, Aittoniemi J. New concepts in the pathogenesis, diagnosis and treatment of bacteremia and sepsis. J Infect. 2011;63(6):407\u201319.","journal-title":"J Infect"},{"issue":"3","key":"21_CR9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/clpt.2009.122","volume":"86","author":"EJ Septimus","year":"2009","unstructured":"Septimus EJ, Kuper KM. Clinical challenges in addressing resistance to antimicrobial drugs in the twenty-first century. Clin Pharmacol Ther. 2009;86(3):336\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"21_CR10","doi-asserted-by":"crossref","first-page":"S315","DOI":"10.1097\/CCM.0b013e3181e6a2a4","volume":"38","author":"TN Gandhi","year":"2010","unstructured":"Gandhi TN, DePestel DD, Collins CD, et al. Managing antimicrobial resistance in intensive care units. Crit Care Med. 2010;38(8):S315\u201323.","journal-title":"Crit Care Med"},{"issue":"6","key":"21_CR11","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1469-0691.2009.02940.x","volume":"16","author":"F Wallet","year":"2010","unstructured":"Wallet F, Nseir S, Baumann L, et al. Preliminary clinical study using a multiplex real-time PCR test for the detection of bacterial and fungal DNA directly in blood. Clin Microbiol Infect. 2010;16(6):774\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"21_CR12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jhin.2010.09.033","volume":"77","author":"YM Alahmadi","year":"2011","unstructured":"Alahmadi YM, Aldeyab MA, McElnay JC, et al. Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect. 2011;77(3):233\u20136.","journal-title":"J Hosp Infect"},{"issue":"1","key":"21_CR13","first-page":"296","volume":"36","author":"RP Dellinger","year":"2008","unstructured":"Dellinger RP, Levy MM, Carlet JM. Surviving Sepsis Campaign: international guidelines for the management of severe sepsis and septic shock 2008 (published erratum appears in Intensive Care Med 2008;36(4):1394\u20136). Intensive Care Med. 2008;36(1):296\u2013327.","journal-title":"Intensive Care Med"},{"issue":"5","key":"21_CR14","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jhm.115","volume":"1","author":"O Zwang","year":"2006","unstructured":"Zwang O, Albert RK. Analysis of strategies to improve cost effectiveness of blood cultures. J Hosp Med. 2006;1(5):272\u20136.","journal-title":"J Hosp Med"},{"key":"21_CR15","unstructured":"US FDA. Clinical Laboratory Improvement Amendments (CLIA). http:\/\/www.fda.gov\/MedicalDevices\/DeviceRegulationandGuidance\/IVDRegulatoryAssistance\/ucm124105.htm . Accessed 29 Nov 2012."},{"key":"21_CR16","unstructured":"US FDA. Evaluation of automatic Class III designation (de novo) for Verigene\u00ae Gram-Positive Blood Culture Nucleic Acid Test (BC-GP). http:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/K113450.pdf . Accessed 8 Oct 2012."},{"key":"21_CR17","unstructured":"Buchan BW, Mackey T-L, Cahak C, et al. Rapid detection of Gram-positive bacteria and resistance determinants directly from positive blood cultures using the microarray-based sample-to-result Verigene BC-GP assay (poster no. P-1700). In: 22nd European Congress of Clinical Microbiology and Infectious Diseases, London, 31 Mar\u20133 Apr 2012."},{"key":"21_CR18","unstructured":"Tormo N, Medina R, Ocete MD, et al. Performance of the nanosphere\u2019s Verigene BC-GP test for rapid detection of Gram-positive bacteria and resistance determinants directly from positive blood cultures (poster). In: 22nd European Congress of Clinical Microbiology and Infectious Diseases, London, 31 Mar\u20133 Apr 2012."},{"key":"21_CR19","unstructured":"Buchan BW, Mackey T, Cahak C, et al. Evaluation of the microarray-based sample-to-result Verigene BC-GP assay for rapid detection of Gram-positive bacteria and resistance determinants directly from positive blood cultures (abstract). In: 51st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, 17\u201320 Sep 2011."},{"key":"21_CR20","unstructured":"Anderson C, Kaul K, Voss B, et al. Evaluation of the Verigene Gram-positive blood culture test (BC-GP) (poster no. 1163). In: 112th American Society for Microbiology General Meeting, San Francisco, 16\u201319 Jun 2012."}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-013-0021-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40291-013-0021-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-013-0021-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,6]],"date-time":"2022-02-06T16:34:17Z","timestamp":1644165257000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40291-013-0021-z"}},"subtitle":["An In Vitro Diagnostic Assay for Identification of Gram-Positive Bacteria Associated with Bloodstream Infections and Bacterial Resistance Markers"],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s40291-013-0021-z","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]}}}